| 2.6 |
13.0 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 2.5 |
7.6 |
GO:1900020 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 2.2 |
13.0 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 2.2 |
10.8 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 2.1 |
6.2 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 2.0 |
6.1 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 2.0 |
8.0 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 2.0 |
6.0 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 2.0 |
2.0 |
GO:0072199 |
mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
| 1.9 |
3.9 |
GO:0072103 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 1.9 |
9.3 |
GO:1903598 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) positive regulation of gap junction assembly(GO:1903598) |
| 1.8 |
5.5 |
GO:0072138 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 1.8 |
5.4 |
GO:0097402 |
neuroblast migration(GO:0097402) |
| 1.7 |
5.1 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 1.7 |
5.1 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 1.7 |
1.7 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 1.6 |
9.7 |
GO:1902998 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of tau-protein kinase activity(GO:1902949) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 1.6 |
6.5 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 1.6 |
1.6 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 1.6 |
3.2 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 1.6 |
12.6 |
GO:0070447 |
positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 1.6 |
4.7 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 1.5 |
1.5 |
GO:0060214 |
endocardium formation(GO:0060214) |
| 1.5 |
4.6 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 1.5 |
6.1 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 1.5 |
4.5 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 1.5 |
4.5 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 1.5 |
1.5 |
GO:0061074 |
regulation of neural retina development(GO:0061074) |
| 1.5 |
1.5 |
GO:0061047 |
positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 1.4 |
5.7 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 1.4 |
4.3 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) |
| 1.4 |
4.3 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 1.4 |
1.4 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 1.4 |
1.4 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 1.4 |
11.3 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 1.4 |
8.4 |
GO:0090500 |
endocardial cushion to mesenchymal transition(GO:0090500) |
| 1.4 |
4.1 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
| 1.3 |
1.3 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 1.3 |
4.0 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 1.3 |
1.3 |
GO:0060066 |
oviduct development(GO:0060066) |
| 1.3 |
11.8 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 1.3 |
3.9 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 1.3 |
2.5 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 1.3 |
3.8 |
GO:0048819 |
regulation of hair follicle maturation(GO:0048819) regulation of catagen(GO:0051794) |
| 1.3 |
3.8 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 1.2 |
1.2 |
GO:1905005 |
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 1.2 |
4.9 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 1.2 |
4.8 |
GO:0035624 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 1.2 |
3.6 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 1.2 |
1.2 |
GO:0002339 |
B cell selection(GO:0002339) |
| 1.2 |
4.7 |
GO:0010046 |
response to mycotoxin(GO:0010046) |
| 1.2 |
4.7 |
GO:0035934 |
corticosterone secretion(GO:0035934) |
| 1.2 |
3.5 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 1.2 |
2.3 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 1.1 |
11.5 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 1.1 |
3.4 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 1.1 |
2.3 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 1.1 |
7.9 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 1.1 |
3.4 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 1.1 |
5.6 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 1.1 |
1.1 |
GO:0035878 |
nail development(GO:0035878) |
| 1.1 |
1.1 |
GO:1902338 |
negative regulation of apoptotic process involved in morphogenesis(GO:1902338) negative regulation of apoptotic process involved in development(GO:1904746) |
| 1.1 |
5.6 |
GO:0001705 |
ectoderm formation(GO:0001705) |
| 1.1 |
5.4 |
GO:0032902 |
nerve growth factor production(GO:0032902) |
| 1.1 |
3.3 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 1.1 |
7.6 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 1.1 |
1.1 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 1.1 |
2.1 |
GO:0003195 |
tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
| 1.0 |
1.0 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 1.0 |
3.1 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 1.0 |
5.1 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 1.0 |
4.1 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 1.0 |
3.0 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 1.0 |
5.1 |
GO:0015871 |
choline transport(GO:0015871) |
| 1.0 |
4.0 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 1.0 |
1.0 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 1.0 |
8.0 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 1.0 |
7.0 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 1.0 |
1.0 |
GO:0006658 |
phosphatidylserine metabolic process(GO:0006658) |
| 1.0 |
1.0 |
GO:0007044 |
cell-substrate junction assembly(GO:0007044) |
| 1.0 |
1.0 |
GO:0010692 |
regulation of alkaline phosphatase activity(GO:0010692) positive regulation of alkaline phosphatase activity(GO:0010694) |
| 1.0 |
4.8 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 1.0 |
1.0 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 1.0 |
2.9 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.9 |
1.9 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.9 |
2.8 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.9 |
2.8 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.9 |
3.7 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 0.9 |
1.8 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.9 |
3.6 |
GO:0071280 |
cellular response to copper ion(GO:0071280) |
| 0.9 |
1.8 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
| 0.9 |
0.9 |
GO:0060279 |
positive regulation of ovulation(GO:0060279) |
| 0.9 |
5.3 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.9 |
3.5 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.9 |
4.4 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.9 |
2.6 |
GO:0035793 |
cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 0.9 |
1.7 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.9 |
3.5 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.9 |
3.5 |
GO:0030222 |
eosinophil differentiation(GO:0030222) |
| 0.9 |
2.6 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.9 |
1.7 |
GO:1903596 |
regulation of gap junction assembly(GO:1903596) |
| 0.9 |
1.7 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.9 |
4.3 |
GO:0072338 |
creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
| 0.9 |
6.0 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.9 |
1.7 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.9 |
4.3 |
GO:0034374 |
low-density lipoprotein particle remodeling(GO:0034374) |
| 0.9 |
2.6 |
GO:0019530 |
taurine metabolic process(GO:0019530) |
| 0.9 |
2.6 |
GO:0007494 |
midgut development(GO:0007494) |
| 0.9 |
2.6 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 0.8 |
3.3 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.8 |
4.1 |
GO:0031944 |
negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
| 0.8 |
2.5 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.8 |
1.6 |
GO:0034372 |
very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.8 |
1.6 |
GO:0006681 |
galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
| 0.8 |
2.4 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.8 |
10.6 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.8 |
0.8 |
GO:0061626 |
pharyngeal arch artery morphogenesis(GO:0061626) |
| 0.8 |
0.8 |
GO:0003104 |
positive regulation of glomerular filtration(GO:0003104) |
| 0.8 |
1.6 |
GO:0090027 |
negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.8 |
2.4 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.8 |
4.8 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.8 |
0.8 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.8 |
4.8 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.8 |
1.6 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.8 |
2.4 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.8 |
0.8 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.8 |
7.0 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.8 |
5.4 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.8 |
7.0 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.8 |
0.8 |
GO:0010873 |
positive regulation of cholesterol esterification(GO:0010873) |
| 0.8 |
0.8 |
GO:0060455 |
negative regulation of gastric acid secretion(GO:0060455) |
| 0.8 |
3.9 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.8 |
3.9 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.8 |
0.8 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.8 |
0.8 |
GO:0042637 |
catagen(GO:0042637) |
| 0.8 |
0.8 |
GO:0014050 |
negative regulation of glutamate secretion(GO:0014050) |
| 0.8 |
0.8 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.8 |
2.3 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.8 |
0.8 |
GO:0001946 |
lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
| 0.7 |
1.5 |
GO:0021649 |
vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) dorsal root ganglion development(GO:1990791) |
| 0.7 |
0.7 |
GO:1903416 |
response to glycoside(GO:1903416) |
| 0.7 |
2.2 |
GO:1905050 |
positive regulation of metalloendopeptidase activity(GO:1904685) positive regulation of metallopeptidase activity(GO:1905050) |
| 0.7 |
3.0 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 0.7 |
2.2 |
GO:1902744 |
negative regulation of lamellipodium organization(GO:1902744) |
| 0.7 |
2.2 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) |
| 0.7 |
2.2 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 0.7 |
0.7 |
GO:0002678 |
positive regulation of chronic inflammatory response(GO:0002678) |
| 0.7 |
0.7 |
GO:0002730 |
regulation of dendritic cell cytokine production(GO:0002730) |
| 0.7 |
3.6 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.7 |
3.6 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.7 |
5.1 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.7 |
1.4 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.7 |
1.4 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.7 |
2.2 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) |
| 0.7 |
9.4 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.7 |
2.2 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.7 |
0.7 |
GO:0003418 |
growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.7 |
2.9 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.7 |
2.9 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.7 |
2.1 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.7 |
2.1 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.7 |
0.7 |
GO:0021593 |
rhombomere morphogenesis(GO:0021593) |
| 0.7 |
2.1 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.7 |
1.4 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 0.7 |
2.1 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 0.7 |
4.9 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.7 |
5.6 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.7 |
1.4 |
GO:0072191 |
ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
| 0.7 |
7.7 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.7 |
0.7 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.7 |
0.7 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 0.7 |
1.4 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.7 |
3.4 |
GO:0010273 |
detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
| 0.7 |
2.7 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.7 |
2.7 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.7 |
0.7 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.7 |
0.7 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.7 |
4.1 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.7 |
4.8 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.7 |
0.7 |
GO:0033084 |
regulation of immature T cell proliferation in thymus(GO:0033084) |
| 0.7 |
3.4 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.7 |
0.7 |
GO:0014719 |
skeletal muscle satellite cell activation(GO:0014719) |
| 0.7 |
1.4 |
GO:1903275 |
positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
| 0.7 |
2.0 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.7 |
0.7 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.7 |
1.3 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.7 |
2.0 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.7 |
6.7 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 0.7 |
2.0 |
GO:0045915 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.7 |
0.7 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.7 |
2.0 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.7 |
1.3 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.7 |
6.7 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.7 |
2.0 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 0.7 |
8.0 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.7 |
2.0 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.7 |
0.7 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.7 |
2.0 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.7 |
1.3 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.7 |
0.7 |
GO:0071726 |
response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.7 |
5.9 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.7 |
4.6 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.7 |
2.6 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.6 |
1.3 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.6 |
1.9 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.6 |
1.3 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.6 |
1.3 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.6 |
2.6 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.6 |
1.3 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) |
| 0.6 |
5.8 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.6 |
2.6 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.6 |
1.9 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.6 |
1.3 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.6 |
7.6 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.6 |
5.1 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.6 |
16.5 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.6 |
0.6 |
GO:0001798 |
type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type II hypersensitivity(GO:0002445) positive regulation of hypersensitivity(GO:0002885) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) type I hypersensitivity(GO:0016068) |
| 0.6 |
1.9 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.6 |
1.9 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.6 |
2.5 |
GO:0060379 |
cardiac muscle cell myoblast differentiation(GO:0060379) |
| 0.6 |
1.9 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.6 |
0.6 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 0.6 |
3.8 |
GO:2000254 |
regulation of male germ cell proliferation(GO:2000254) |
| 0.6 |
3.1 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.6 |
3.1 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.6 |
1.9 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.6 |
1.9 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
| 0.6 |
5.6 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.6 |
2.5 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.6 |
1.8 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.6 |
0.6 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.6 |
0.6 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.6 |
1.8 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.6 |
3.6 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.6 |
1.2 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.6 |
6.6 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.6 |
2.4 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.6 |
3.0 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.6 |
0.6 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.6 |
1.8 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.6 |
2.4 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.6 |
1.8 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.6 |
1.2 |
GO:0009169 |
purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
| 0.6 |
3.0 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.6 |
2.4 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.6 |
0.6 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) |
| 0.6 |
1.2 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 0.6 |
1.8 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.6 |
1.8 |
GO:0060750 |
epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
| 0.6 |
1.2 |
GO:1900158 |
negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.6 |
6.4 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.6 |
1.2 |
GO:0042220 |
response to cocaine(GO:0042220) |
| 0.6 |
0.6 |
GO:0035510 |
DNA dealkylation(GO:0035510) |
| 0.6 |
2.9 |
GO:1904721 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.6 |
2.3 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.6 |
2.9 |
GO:0014866 |
skeletal myofibril assembly(GO:0014866) |
| 0.6 |
1.7 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.6 |
3.4 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.6 |
4.6 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.6 |
4.0 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.6 |
1.1 |
GO:0051695 |
actin filament uncapping(GO:0051695) |
| 0.6 |
2.3 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.6 |
1.1 |
GO:0044413 |
evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 0.6 |
2.2 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.6 |
6.1 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.6 |
1.7 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.6 |
2.2 |
GO:0001765 |
membrane raft assembly(GO:0001765) |
| 0.6 |
1.1 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.6 |
4.4 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.6 |
0.6 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.5 |
0.5 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.5 |
2.7 |
GO:0010454 |
negative regulation of cell fate commitment(GO:0010454) |
| 0.5 |
0.5 |
GO:0099624 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.5 |
2.2 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.5 |
2.7 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.5 |
1.1 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.5 |
1.6 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.5 |
0.5 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.5 |
3.8 |
GO:0033561 |
regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
| 0.5 |
2.7 |
GO:2001204 |
regulation of osteoclast development(GO:2001204) |
| 0.5 |
1.1 |
GO:2000981 |
negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
| 0.5 |
0.5 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.5 |
1.6 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.5 |
1.6 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.5 |
1.6 |
GO:0045414 |
regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 0.5 |
2.1 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.5 |
0.5 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.5 |
2.7 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 |
2.1 |
GO:1904426 |
positive regulation of GTP binding(GO:1904426) regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 0.5 |
2.6 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.5 |
1.1 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.5 |
1.1 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.5 |
10.5 |
GO:0046596 |
regulation of viral entry into host cell(GO:0046596) |
| 0.5 |
1.6 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
| 0.5 |
1.0 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.5 |
2.1 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) |
| 0.5 |
3.7 |
GO:0071404 |
cellular response to lipoprotein particle stimulus(GO:0071402) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
| 0.5 |
2.6 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.5 |
3.1 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.5 |
1.6 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.5 |
3.1 |
GO:0072243 |
metanephric nephron epithelium development(GO:0072243) |
| 0.5 |
0.5 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.5 |
2.0 |
GO:0048678 |
response to axon injury(GO:0048678) |
| 0.5 |
4.6 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.5 |
4.1 |
GO:1903019 |
negative regulation of glycoprotein metabolic process(GO:1903019) |
| 0.5 |
1.5 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.5 |
2.5 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.5 |
2.5 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.5 |
4.0 |
GO:0031645 |
negative regulation of neurological system process(GO:0031645) |
| 0.5 |
4.0 |
GO:0042984 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.5 |
1.5 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.5 |
1.5 |
GO:0036509 |
trimming of terminal mannose on B branch(GO:0036509) |
| 0.5 |
3.0 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.5 |
5.0 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.5 |
3.0 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.5 |
0.5 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 0.5 |
11.3 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.5 |
1.5 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
| 0.5 |
4.4 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.5 |
1.5 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.5 |
1.0 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.5 |
1.9 |
GO:0044243 |
multicellular organism catabolic process(GO:0044243) |
| 0.5 |
1.5 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.5 |
0.5 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.5 |
1.5 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.5 |
1.5 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.5 |
2.9 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.5 |
2.4 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.5 |
2.4 |
GO:1902513 |
regulation of organelle transport along microtubule(GO:1902513) |
| 0.5 |
1.5 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.5 |
1.4 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.5 |
0.5 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.5 |
2.4 |
GO:0043585 |
nose morphogenesis(GO:0043585) |
| 0.5 |
1.9 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.5 |
1.9 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.5 |
1.4 |
GO:1902608 |
regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
| 0.5 |
5.7 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.5 |
1.4 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.5 |
10.9 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.5 |
0.9 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.5 |
1.9 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.5 |
1.4 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.5 |
3.3 |
GO:0060347 |
heart trabecula formation(GO:0060347) |
| 0.5 |
1.9 |
GO:0045136 |
development of secondary sexual characteristics(GO:0045136) |
| 0.5 |
1.4 |
GO:0014742 |
positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
| 0.5 |
1.4 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.5 |
1.4 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.5 |
0.5 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.5 |
0.5 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.5 |
2.3 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.5 |
2.8 |
GO:0000050 |
urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 0.5 |
0.5 |
GO:1903525 |
regulation of membrane tubulation(GO:1903525) |
| 0.5 |
0.9 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.5 |
1.4 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.5 |
2.3 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.5 |
3.2 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.5 |
1.8 |
GO:0051497 |
negative regulation of actin filament bundle assembly(GO:0032232) negative regulation of stress fiber assembly(GO:0051497) |
| 0.5 |
1.4 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
| 0.5 |
0.5 |
GO:0038171 |
cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
| 0.5 |
0.5 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.5 |
1.4 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.4 |
0.4 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.4 |
0.4 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) |
| 0.4 |
0.4 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.4 |
1.3 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.4 |
1.8 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.4 |
0.4 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.4 |
0.9 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.4 |
0.4 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 0.4 |
1.3 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.4 |
0.9 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.4 |
0.4 |
GO:0014002 |
astrocyte development(GO:0014002) |
| 0.4 |
1.8 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.4 |
1.3 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.4 |
0.9 |
GO:0061314 |
Notch signaling involved in heart development(GO:0061314) |
| 0.4 |
0.9 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.4 |
2.2 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.4 |
1.8 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.4 |
2.2 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.4 |
1.3 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.4 |
0.4 |
GO:0034113 |
heterotypic cell-cell adhesion(GO:0034113) |
| 0.4 |
2.2 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.4 |
1.3 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.4 |
1.3 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.4 |
0.9 |
GO:2000851 |
positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.4 |
0.4 |
GO:0045659 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.4 |
0.4 |
GO:0032805 |
positive regulation of low-density lipoprotein particle receptor catabolic process(GO:0032805) |
| 0.4 |
2.1 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.4 |
1.3 |
GO:0070782 |
phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.4 |
0.9 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.4 |
1.3 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 0.4 |
1.3 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.4 |
4.3 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.4 |
0.8 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.4 |
2.1 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.4 |
0.4 |
GO:0061043 |
regulation of vascular wound healing(GO:0061043) |
| 0.4 |
1.3 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.4 |
0.4 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.4 |
0.4 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.4 |
1.7 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.4 |
0.4 |
GO:2000427 |
regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.4 |
0.8 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.4 |
0.4 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.4 |
0.4 |
GO:0034124 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.4 |
0.8 |
GO:2000987 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.4 |
1.7 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.4 |
2.1 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.4 |
0.8 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.4 |
1.2 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.4 |
1.2 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.4 |
0.4 |
GO:0048505 |
regulation of timing of cell differentiation(GO:0048505) |
| 0.4 |
1.2 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.4 |
4.6 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.4 |
3.3 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.4 |
0.4 |
GO:0042482 |
positive regulation of odontogenesis(GO:0042482) |
| 0.4 |
7.8 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.4 |
0.4 |
GO:1990000 |
amyloid fibril formation(GO:1990000) |
| 0.4 |
1.6 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.4 |
1.2 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.4 |
2.9 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.4 |
1.2 |
GO:1904395 |
positive regulation of receptor clustering(GO:1903911) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.4 |
0.4 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.4 |
3.7 |
GO:0015865 |
purine nucleotide transport(GO:0015865) |
| 0.4 |
0.8 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.4 |
3.2 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.4 |
2.0 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.4 |
2.0 |
GO:0031659 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
| 0.4 |
4.0 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.4 |
1.2 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.4 |
4.8 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.4 |
2.4 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.4 |
2.0 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.4 |
0.8 |
GO:0042517 |
positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
| 0.4 |
0.4 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.4 |
0.8 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.4 |
1.6 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.4 |
1.6 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.4 |
0.4 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.4 |
0.8 |
GO:0002478 |
antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
| 0.4 |
1.2 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.4 |
2.0 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.4 |
1.2 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
| 0.4 |
0.4 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.4 |
0.4 |
GO:2000109 |
macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
| 0.4 |
2.0 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.4 |
2.4 |
GO:0021940 |
positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.4 |
0.4 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.4 |
1.2 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.4 |
1.9 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.4 |
2.7 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.4 |
0.8 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.4 |
1.9 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.4 |
1.2 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.4 |
2.7 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.4 |
0.8 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.4 |
5.0 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.4 |
0.4 |
GO:0008354 |
germ cell migration(GO:0008354) |
| 0.4 |
2.3 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.4 |
0.8 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.4 |
10.7 |
GO:0032355 |
response to estradiol(GO:0032355) |
| 0.4 |
6.1 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.4 |
1.1 |
GO:0015824 |
proline transport(GO:0015824) |
| 0.4 |
0.8 |
GO:0003062 |
regulation of heart rate by chemical signal(GO:0003062) |
| 0.4 |
1.1 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.4 |
0.4 |
GO:0071107 |
response to parathyroid hormone(GO:0071107) |
| 0.4 |
1.1 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.4 |
1.5 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.4 |
1.5 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.4 |
0.8 |
GO:0002295 |
T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) |
| 0.4 |
0.7 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
| 0.4 |
1.1 |
GO:0048382 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) mesendoderm development(GO:0048382) |
| 0.4 |
0.4 |
GO:0003419 |
growth plate cartilage chondrocyte proliferation(GO:0003419) regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.4 |
2.2 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.4 |
1.9 |
GO:0007369 |
gastrulation(GO:0007369) |
| 0.4 |
0.7 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.4 |
4.1 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.4 |
1.5 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.4 |
1.1 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.4 |
2.2 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.4 |
4.4 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.4 |
3.3 |
GO:0046643 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.4 |
0.4 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.4 |
0.4 |
GO:0003241 |
growth involved in heart morphogenesis(GO:0003241) |
| 0.4 |
0.7 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.4 |
1.5 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.4 |
0.7 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.4 |
1.8 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.4 |
1.1 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.4 |
5.0 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.4 |
1.1 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.4 |
3.2 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.4 |
2.1 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.4 |
3.2 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.4 |
0.4 |
GO:0043416 |
regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.4 |
1.4 |
GO:0051963 |
regulation of synapse assembly(GO:0051963) |
| 0.4 |
0.4 |
GO:0002438 |
acute inflammatory response to antigenic stimulus(GO:0002438) |
| 0.4 |
2.5 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.4 |
1.8 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.4 |
1.1 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 0.4 |
0.4 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.4 |
1.1 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.4 |
0.7 |
GO:0032493 |
response to bacterial lipoprotein(GO:0032493) |
| 0.4 |
1.4 |
GO:0033580 |
protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.4 |
0.4 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.4 |
1.4 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.4 |
0.7 |
GO:0071910 |
determination of liver left/right asymmetry(GO:0071910) |
| 0.4 |
12.0 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.4 |
1.8 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.4 |
1.1 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.4 |
1.4 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.4 |
1.1 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.4 |
1.1 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.4 |
1.8 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.4 |
0.4 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.3 |
0.3 |
GO:1902415 |
regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
| 0.3 |
7.3 |
GO:0010862 |
positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.3 |
0.3 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.3 |
4.5 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.3 |
1.0 |
GO:0043465 |
regulation of fermentation(GO:0043465) negative regulation of fermentation(GO:1901003) |
| 0.3 |
0.3 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.3 |
0.7 |
GO:0031652 |
positive regulation of heat generation(GO:0031652) |
| 0.3 |
0.3 |
GO:0045410 |
positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.3 |
2.8 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.3 |
0.7 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.3 |
1.4 |
GO:0071499 |
response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
| 0.3 |
2.1 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.3 |
1.0 |
GO:2000316 |
regulation of T-helper 17 type immune response(GO:2000316) |
| 0.3 |
0.3 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.3 |
4.5 |
GO:0021514 |
ventral spinal cord interneuron differentiation(GO:0021514) |
| 0.3 |
2.4 |
GO:0031641 |
regulation of myelination(GO:0031641) |
| 0.3 |
1.0 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.3 |
1.7 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.3 |
2.4 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.3 |
2.0 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.3 |
0.7 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.3 |
1.4 |
GO:0042711 |
maternal behavior(GO:0042711) |
| 0.3 |
0.7 |
GO:0060315 |
negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.3 |
1.7 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.3 |
4.1 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.3 |
1.7 |
GO:0060055 |
angiogenesis involved in wound healing(GO:0060055) |
| 0.3 |
2.0 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.3 |
1.7 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.3 |
0.3 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) |
| 0.3 |
4.0 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.3 |
0.3 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.3 |
0.3 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.3 |
0.7 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.3 |
0.7 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.3 |
5.7 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.3 |
0.3 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.3 |
0.7 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.3 |
1.0 |
GO:0030325 |
adrenal gland development(GO:0030325) |
| 0.3 |
3.3 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.3 |
2.7 |
GO:0071816 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.3 |
1.3 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.3 |
1.0 |
GO:0032278 |
positive regulation of gonadotropin secretion(GO:0032278) |
| 0.3 |
1.3 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.3 |
1.7 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.3 |
1.0 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.3 |
1.3 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.3 |
0.3 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.3 |
0.7 |
GO:0034135 |
regulation of toll-like receptor 2 signaling pathway(GO:0034135) positive regulation of defense response to bacterium(GO:1900426) |
| 0.3 |
1.0 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.3 |
1.3 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.3 |
0.7 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.3 |
1.6 |
GO:0051084 |
'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
| 0.3 |
0.3 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.3 |
0.3 |
GO:0055010 |
ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
| 0.3 |
0.6 |
GO:0015817 |
histidine transport(GO:0015817) |
| 0.3 |
1.6 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.3 |
1.9 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.3 |
0.3 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.3 |
1.9 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.3 |
2.9 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.3 |
0.3 |
GO:0010573 |
vascular endothelial growth factor production(GO:0010573) |
| 0.3 |
0.3 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.3 |
0.3 |
GO:0045188 |
circadian sleep/wake cycle, non-REM sleep(GO:0042748) regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
| 0.3 |
1.0 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) |
| 0.3 |
8.3 |
GO:0048701 |
embryonic cranial skeleton morphogenesis(GO:0048701) |
| 0.3 |
0.3 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.3 |
0.3 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.3 |
1.0 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.3 |
0.3 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.3 |
3.5 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.3 |
0.3 |
GO:0071316 |
cellular response to nicotine(GO:0071316) |
| 0.3 |
0.3 |
GO:0051180 |
vitamin transport(GO:0051180) |
| 0.3 |
0.6 |
GO:0046084 |
adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
| 0.3 |
0.6 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 0.3 |
2.2 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.3 |
0.6 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.3 |
1.3 |
GO:0050812 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.3 |
2.5 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.3 |
1.3 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.3 |
1.2 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.3 |
0.3 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.3 |
4.7 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.3 |
0.9 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 0.3 |
1.9 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.3 |
0.6 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.3 |
2.2 |
GO:0010748 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.3 |
0.3 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.3 |
0.9 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.3 |
0.9 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.3 |
0.6 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.3 |
0.9 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.3 |
0.9 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.3 |
3.4 |
GO:0030166 |
proteoglycan biosynthetic process(GO:0030166) |
| 0.3 |
3.7 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.3 |
0.6 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.3 |
0.3 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.3 |
0.6 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.3 |
1.8 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.3 |
0.3 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.3 |
0.3 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.3 |
1.2 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.3 |
3.9 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.3 |
0.6 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.3 |
1.5 |
GO:0055093 |
response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
| 0.3 |
1.2 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.3 |
0.6 |
GO:2000020 |
positive regulation of male gonad development(GO:2000020) |
| 0.3 |
0.6 |
GO:0032096 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.3 |
0.3 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.3 |
0.6 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.3 |
1.5 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.3 |
0.9 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.3 |
0.9 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.3 |
0.3 |
GO:1904749 |
regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.3 |
0.9 |
GO:2000489 |
hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
| 0.3 |
1.2 |
GO:1901984 |
negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
| 0.3 |
0.3 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.3 |
0.9 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.3 |
2.6 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.3 |
0.3 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.3 |
0.3 |
GO:0060914 |
heart formation(GO:0060914) |
| 0.3 |
0.9 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.3 |
1.2 |
GO:0042135 |
neurotransmitter catabolic process(GO:0042135) |
| 0.3 |
1.2 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.3 |
0.9 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.3 |
0.9 |
GO:1901163 |
trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) negative regulation of trophoblast cell migration(GO:1901164) |
| 0.3 |
0.3 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.3 |
2.6 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.3 |
0.3 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.3 |
0.6 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.3 |
1.7 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.3 |
0.3 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.3 |
4.6 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.3 |
0.3 |
GO:0014834 |
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 0.3 |
1.1 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.3 |
0.3 |
GO:0042640 |
anagen(GO:0042640) |
| 0.3 |
0.6 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.3 |
1.4 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.3 |
1.1 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.3 |
1.1 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.3 |
2.0 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.3 |
0.3 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.3 |
2.0 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.3 |
0.8 |
GO:0060412 |
ventricular septum morphogenesis(GO:0060412) |
| 0.3 |
2.0 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.3 |
1.4 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.3 |
5.0 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.3 |
0.8 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.3 |
4.4 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
| 0.3 |
0.8 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.3 |
1.7 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.3 |
1.4 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.3 |
0.3 |
GO:0046499 |
S-adenosylmethioninamine metabolic process(GO:0046499) |
| 0.3 |
2.5 |
GO:0030220 |
platelet formation(GO:0030220) |
| 0.3 |
1.4 |
GO:1902166 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.3 |
1.4 |
GO:0016093 |
polyprenol metabolic process(GO:0016093) |
| 0.3 |
0.3 |
GO:0010896 |
regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.3 |
0.3 |
GO:0001885 |
endothelial cell development(GO:0001885) |
| 0.3 |
0.8 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.3 |
0.5 |
GO:0030512 |
negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.3 |
1.4 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.3 |
0.3 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.3 |
4.9 |
GO:0046185 |
aldehyde catabolic process(GO:0046185) |
| 0.3 |
0.3 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.3 |
0.3 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.3 |
0.5 |
GO:0070257 |
positive regulation of mucus secretion(GO:0070257) |
| 0.3 |
3.0 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.3 |
0.3 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.3 |
0.3 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.3 |
1.4 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.3 |
1.9 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.3 |
0.8 |
GO:0019346 |
homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.3 |
0.8 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.3 |
0.5 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.3 |
0.3 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.3 |
1.9 |
GO:0043277 |
apoptotic cell clearance(GO:0043277) |
| 0.3 |
0.8 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.3 |
0.5 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.3 |
1.3 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.3 |
0.5 |
GO:1903912 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.3 |
0.3 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.3 |
0.5 |
GO:0060742 |
epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.3 |
0.3 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.3 |
0.8 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 0.3 |
0.3 |
GO:0051926 |
negative regulation of calcium ion transport(GO:0051926) |
| 0.3 |
1.9 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.3 |
0.8 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.3 |
2.6 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.3 |
0.5 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
| 0.3 |
1.1 |
GO:0031069 |
hair follicle morphogenesis(GO:0031069) |
| 0.3 |
0.3 |
GO:0036344 |
platelet morphogenesis(GO:0036344) |
| 0.3 |
0.3 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.3 |
0.3 |
GO:1900221 |
regulation of beta-amyloid clearance(GO:1900221) |
| 0.3 |
0.8 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.3 |
0.5 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.3 |
1.8 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.3 |
0.8 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.3 |
0.5 |
GO:0043497 |
regulation of protein heterodimerization activity(GO:0043497) |
| 0.3 |
0.5 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.3 |
0.3 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.3 |
0.3 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.3 |
1.0 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 0.3 |
0.8 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.3 |
1.0 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.3 |
0.3 |
GO:0060438 |
trachea development(GO:0060438) |
| 0.3 |
0.8 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) ether lipid metabolic process(GO:0046485) |
| 0.3 |
1.0 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.3 |
0.3 |
GO:0045453 |
bone resorption(GO:0045453) |
| 0.3 |
2.3 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.3 |
0.8 |
GO:0050810 |
regulation of steroid biosynthetic process(GO:0050810) |
| 0.3 |
0.5 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.3 |
1.5 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.3 |
0.5 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.3 |
1.0 |
GO:0009227 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.3 |
0.8 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.3 |
1.5 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.3 |
1.3 |
GO:0031644 |
regulation of neurological system process(GO:0031644) |
| 0.3 |
11.4 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.3 |
0.5 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.3 |
2.0 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.3 |
1.3 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.3 |
0.3 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.3 |
0.5 |
GO:2000398 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.2 |
0.2 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.2 |
1.0 |
GO:0003263 |
cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.2 |
1.0 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.2 |
0.2 |
GO:0061365 |
positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.2 |
2.5 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 |
0.7 |
GO:1904729 |
regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
| 0.2 |
0.5 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.2 |
0.5 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.2 |
11.9 |
GO:0071230 |
cellular response to amino acid stimulus(GO:0071230) |
| 0.2 |
0.7 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.2 |
1.2 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.2 |
0.5 |
GO:0003310 |
pancreatic A cell differentiation(GO:0003310) |
| 0.2 |
0.7 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.2 |
0.7 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.2 |
0.2 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.2 |
0.5 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.2 |
0.7 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.2 |
1.2 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.2 |
0.5 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.2 |
0.7 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.2 |
0.7 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.2 |
1.2 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.2 |
6.0 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.2 |
0.2 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.2 |
0.2 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
| 0.2 |
1.9 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.2 |
3.4 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.2 |
1.0 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.2 |
0.5 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.2 |
0.7 |
GO:0006027 |
glycosaminoglycan catabolic process(GO:0006027) |
| 0.2 |
0.2 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.2 |
2.4 |
GO:1903077 |
negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.2 |
0.5 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.2 |
2.9 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.2 |
3.1 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.2 |
1.2 |
GO:0001834 |
trophectodermal cell proliferation(GO:0001834) |
| 0.2 |
0.2 |
GO:0014016 |
neuroblast differentiation(GO:0014016) |
| 0.2 |
0.5 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.2 |
1.9 |
GO:0060586 |
multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.2 |
0.7 |
GO:0097006 |
regulation of plasma lipoprotein particle levels(GO:0097006) |
| 0.2 |
0.2 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.2 |
1.7 |
GO:0006144 |
purine nucleobase metabolic process(GO:0006144) |
| 0.2 |
0.9 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.2 |
0.7 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 |
0.9 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.2 |
0.7 |
GO:2000110 |
negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.2 |
0.9 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.2 |
4.0 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.2 |
3.3 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.2 |
3.0 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.2 |
0.7 |
GO:0046112 |
nucleobase biosynthetic process(GO:0046112) |
| 0.2 |
0.9 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.2 |
1.4 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.2 |
0.9 |
GO:0034308 |
primary alcohol metabolic process(GO:0034308) |
| 0.2 |
0.2 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.2 |
3.9 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.2 |
0.2 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.2 |
0.7 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.2 |
0.9 |
GO:1901341 |
positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.2 |
0.5 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.2 |
0.7 |
GO:0033008 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.2 |
0.5 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.2 |
0.5 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.2 |
1.1 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.2 |
2.5 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.2 |
4.8 |
GO:0048662 |
negative regulation of smooth muscle cell proliferation(GO:0048662) |
| 0.2 |
0.2 |
GO:0021847 |
ventricular zone neuroblast division(GO:0021847) |
| 0.2 |
0.2 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.2 |
0.9 |
GO:0048715 |
negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.2 |
1.6 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.2 |
4.7 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.2 |
3.8 |
GO:0001658 |
branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.2 |
0.9 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.2 |
0.2 |
GO:0006833 |
water transport(GO:0006833) |
| 0.2 |
0.7 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.2 |
0.7 |
GO:0000429 |
carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
| 0.2 |
0.4 |
GO:1902262 |
apoptotic process involved in patterning of blood vessels(GO:1902262) |
| 0.2 |
1.1 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.2 |
0.4 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.2 |
1.6 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.2 |
0.9 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.2 |
1.8 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.2 |
1.3 |
GO:0032225 |
regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.2 |
0.7 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.2 |
0.4 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.2 |
0.7 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.2 |
1.3 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.2 |
0.2 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.2 |
0.2 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.2 |
0.2 |
GO:2001171 |
positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.2 |
2.0 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.2 |
0.4 |
GO:0009125 |
nucleoside monophosphate catabolic process(GO:0009125) |
| 0.2 |
0.7 |
GO:0032620 |
interleukin-17 production(GO:0032620) |
| 0.2 |
1.5 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.2 |
0.2 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.2 |
0.4 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.2 |
1.3 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.2 |
0.4 |
GO:0046470 |
phosphatidylcholine metabolic process(GO:0046470) |
| 0.2 |
0.2 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.2 |
2.4 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.2 |
0.2 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.2 |
0.2 |
GO:0010911 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
| 0.2 |
0.6 |
GO:0001964 |
startle response(GO:0001964) |
| 0.2 |
2.1 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.2 |
1.3 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.2 |
0.6 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.2 |
4.9 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.2 |
0.8 |
GO:0019400 |
glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
| 0.2 |
0.4 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.2 |
6.1 |
GO:1903078 |
positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
| 0.2 |
0.4 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.2 |
1.1 |
GO:0010226 |
response to lithium ion(GO:0010226) |
| 0.2 |
4.0 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.2 |
0.2 |
GO:0071600 |
otic vesicle morphogenesis(GO:0071600) |
| 0.2 |
5.7 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.2 |
0.4 |
GO:0014014 |
negative regulation of gliogenesis(GO:0014014) |
| 0.2 |
1.0 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 |
0.6 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.2 |
1.0 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.2 |
2.7 |
GO:0021681 |
cerebellar granular layer development(GO:0021681) |
| 0.2 |
1.3 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.2 |
1.9 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.2 |
0.6 |
GO:0032725 |
positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
| 0.2 |
1.0 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.2 |
0.4 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.2 |
0.8 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.2 |
0.6 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.2 |
2.3 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.2 |
0.6 |
GO:0019042 |
viral latency(GO:0019042) |
| 0.2 |
0.4 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.2 |
0.2 |
GO:1902600 |
hydrogen ion transmembrane transport(GO:1902600) |
| 0.2 |
0.6 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.2 |
0.4 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.2 |
0.6 |
GO:0060912 |
cardiac cell fate commitment(GO:0060911) cardiac cell fate specification(GO:0060912) |
| 0.2 |
0.2 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.2 |
0.4 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.2 |
1.4 |
GO:0072102 |
glomerulus morphogenesis(GO:0072102) |
| 0.2 |
1.4 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.2 |
0.6 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.2 |
0.2 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.2 |
0.2 |
GO:0033028 |
myeloid cell apoptotic process(GO:0033028) |
| 0.2 |
0.2 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.2 |
1.8 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.2 |
0.6 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.2 |
2.0 |
GO:0071801 |
regulation of podosome assembly(GO:0071801) |
| 0.2 |
1.2 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.2 |
0.4 |
GO:0072350 |
tricarboxylic acid metabolic process(GO:0072350) |
| 0.2 |
0.4 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.2 |
0.6 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.2 |
2.0 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.2 |
0.4 |
GO:0050996 |
positive regulation of lipid catabolic process(GO:0050996) |
| 0.2 |
0.2 |
GO:0032829 |
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 0.2 |
0.4 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.2 |
0.4 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.2 |
1.0 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.2 |
0.6 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.2 |
1.6 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.2 |
0.2 |
GO:0006706 |
steroid catabolic process(GO:0006706) |
| 0.2 |
0.4 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.2 |
2.0 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.2 |
1.0 |
GO:0061684 |
chaperone-mediated autophagy(GO:0061684) |
| 0.2 |
0.2 |
GO:0043307 |
eosinophil activation(GO:0043307) |
| 0.2 |
3.7 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.2 |
0.2 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 0.2 |
0.6 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.2 |
1.4 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.2 |
1.0 |
GO:0050716 |
positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.2 |
0.6 |
GO:0036035 |
osteoclast development(GO:0036035) |
| 0.2 |
0.8 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
| 0.2 |
0.4 |
GO:2001240 |
negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.2 |
1.6 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.2 |
1.9 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.2 |
0.2 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.2 |
0.2 |
GO:0032024 |
positive regulation of insulin secretion(GO:0032024) |
| 0.2 |
2.5 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.2 |
1.2 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.2 |
0.6 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 |
2.5 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.2 |
0.6 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.2 |
2.9 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.2 |
0.4 |
GO:1901072 |
glucosamine-containing compound catabolic process(GO:1901072) |
| 0.2 |
0.6 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.2 |
0.2 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.2 |
1.3 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.2 |
1.5 |
GO:0001780 |
neutrophil homeostasis(GO:0001780) |
| 0.2 |
0.8 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.2 |
0.6 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.2 |
0.2 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.2 |
3.4 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.2 |
1.1 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.2 |
0.2 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.2 |
0.9 |
GO:0035588 |
adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
| 0.2 |
0.6 |
GO:0032367 |
intracellular cholesterol transport(GO:0032367) |
| 0.2 |
0.2 |
GO:0071498 |
cellular response to fluid shear stress(GO:0071498) |
| 0.2 |
1.1 |
GO:0032964 |
collagen biosynthetic process(GO:0032964) |
| 0.2 |
0.4 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.2 |
0.2 |
GO:0043954 |
cellular component maintenance(GO:0043954) |
| 0.2 |
1.1 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.2 |
0.2 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.2 |
0.4 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.2 |
1.1 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 |
0.2 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.2 |
1.7 |
GO:0032461 |
positive regulation of protein oligomerization(GO:0032461) |
| 0.2 |
0.2 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.2 |
0.6 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.2 |
0.9 |
GO:0061045 |
negative regulation of wound healing(GO:0061045) |
| 0.2 |
0.4 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.2 |
0.4 |
GO:1903358 |
regulation of Golgi organization(GO:1903358) |
| 0.2 |
0.5 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.2 |
0.4 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 |
0.2 |
GO:0003161 |
cardiac conduction system development(GO:0003161) |
| 0.2 |
0.4 |
GO:0051204 |
protein insertion into mitochondrial membrane(GO:0051204) |
| 0.2 |
2.7 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.2 |
0.5 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
| 0.2 |
6.5 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.2 |
0.2 |
GO:2000343 |
positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
| 0.2 |
2.9 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.2 |
0.2 |
GO:0032077 |
positive regulation of deoxyribonuclease activity(GO:0032077) |
| 0.2 |
0.2 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.2 |
0.7 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.2 |
0.2 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.2 |
1.4 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 |
0.5 |
GO:0042182 |
ketone catabolic process(GO:0042182) |
| 0.2 |
0.7 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.2 |
0.7 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.2 |
2.0 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.2 |
0.9 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.2 |
0.9 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.2 |
0.7 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.2 |
2.3 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.2 |
0.4 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.2 |
0.4 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.2 |
1.2 |
GO:1902969 |
mitotic DNA replication(GO:1902969) |
| 0.2 |
1.4 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.2 |
0.2 |
GO:0090102 |
cochlea development(GO:0090102) |
| 0.2 |
0.3 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.2 |
1.7 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.2 |
0.2 |
GO:0070988 |
demethylation(GO:0070988) |
| 0.2 |
0.5 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.2 |
6.3 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.2 |
0.7 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.2 |
0.3 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.2 |
0.5 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.2 |
2.6 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.2 |
0.7 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.2 |
1.6 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
| 0.2 |
1.2 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.2 |
0.2 |
GO:0060706 |
cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.2 |
0.9 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.2 |
0.2 |
GO:0055094 |
response to lipoprotein particle(GO:0055094) |
| 0.2 |
0.2 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.2 |
1.2 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.2 |
0.2 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.2 |
1.9 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.2 |
0.9 |
GO:0003254 |
regulation of membrane depolarization(GO:0003254) |
| 0.2 |
0.9 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.2 |
0.2 |
GO:0051354 |
negative regulation of oxidoreductase activity(GO:0051354) |
| 0.2 |
0.2 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 0.2 |
0.9 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.2 |
0.7 |
GO:0090311 |
regulation of protein deacetylation(GO:0090311) |
| 0.2 |
0.5 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.2 |
1.0 |
GO:0034766 |
negative regulation of ion transmembrane transport(GO:0034766) |
| 0.2 |
0.3 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.2 |
0.2 |
GO:0048566 |
embryonic digestive tract development(GO:0048566) |
| 0.2 |
1.4 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.2 |
1.0 |
GO:0021924 |
cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.2 |
1.7 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.2 |
0.7 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 |
1.7 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.2 |
0.2 |
GO:0036006 |
response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.2 |
1.0 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.2 |
0.7 |
GO:0042167 |
heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.2 |
0.5 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.2 |
0.5 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.2 |
0.2 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.2 |
0.5 |
GO:0002825 |
regulation of T-helper 1 type immune response(GO:0002825) |
| 0.2 |
1.0 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.2 |
0.2 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.2 |
0.2 |
GO:0002579 |
positive regulation of antigen processing and presentation(GO:0002579) |
| 0.2 |
0.5 |
GO:0009415 |
response to water(GO:0009415) |
| 0.2 |
0.8 |
GO:0015838 |
amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
| 0.2 |
0.5 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.2 |
0.3 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.2 |
0.7 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.2 |
1.2 |
GO:0048844 |
artery morphogenesis(GO:0048844) |
| 0.2 |
1.0 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.2 |
0.3 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.2 |
0.3 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.2 |
3.9 |
GO:0006970 |
response to osmotic stress(GO:0006970) |
| 0.2 |
0.7 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.2 |
3.1 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.2 |
0.7 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.2 |
1.1 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.2 |
0.7 |
GO:0003056 |
regulation of vascular smooth muscle contraction(GO:0003056) |
| 0.2 |
1.0 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.2 |
0.2 |
GO:0035404 |
histone-serine phosphorylation(GO:0035404) |
| 0.2 |
0.3 |
GO:0060352 |
cell adhesion molecule production(GO:0060352) |
| 0.2 |
0.3 |
GO:1902235 |
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.2 |
0.3 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.2 |
0.2 |
GO:0033128 |
negative regulation of histone phosphorylation(GO:0033128) |
| 0.2 |
0.2 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 0.2 |
1.4 |
GO:0007200 |
phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.2 |
5.1 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.2 |
0.2 |
GO:0089700 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) protein kinase D signaling(GO:0089700) |
| 0.2 |
0.5 |
GO:0035553 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.2 |
0.3 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.2 |
1.0 |
GO:1902475 |
L-alpha-amino acid transmembrane transport(GO:1902475) |
| 0.2 |
0.6 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.2 |
0.5 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.2 |
1.9 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.2 |
0.6 |
GO:0070371 |
ERK1 and ERK2 cascade(GO:0070371) |
| 0.2 |
0.5 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.2 |
0.5 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.2 |
0.3 |
GO:0051547 |
keratinocyte migration(GO:0051546) regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
| 0.2 |
0.2 |
GO:0071907 |
determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.2 |
2.0 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.2 |
0.8 |
GO:0002526 |
acute inflammatory response(GO:0002526) |
| 0.2 |
0.5 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.2 |
0.8 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.2 |
1.3 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.2 |
0.8 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.2 |
0.5 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.2 |
0.3 |
GO:0072078 |
nephron morphogenesis(GO:0072028) nephron tubule morphogenesis(GO:0072078) nephron epithelium morphogenesis(GO:0072088) |
| 0.2 |
0.2 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.2 |
1.1 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.2 |
0.5 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.2 |
0.6 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.2 |
0.2 |
GO:0015870 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.2 |
0.2 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.2 |
0.2 |
GO:0042311 |
vasodilation(GO:0042311) |
| 0.2 |
0.8 |
GO:1903020 |
positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.2 |
0.3 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.2 |
0.2 |
GO:0006598 |
polyamine catabolic process(GO:0006598) |
| 0.2 |
0.2 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.2 |
0.2 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.2 |
0.6 |
GO:0010664 |
negative regulation of striated muscle cell apoptotic process(GO:0010664) |
| 0.2 |
1.1 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.2 |
0.2 |
GO:0022028 |
tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
| 0.2 |
0.5 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.2 |
1.2 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.2 |
0.5 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.2 |
0.3 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.2 |
0.5 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.2 |
0.5 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.2 |
2.1 |
GO:0010388 |
protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
| 0.2 |
0.3 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 |
0.6 |
GO:1902992 |
negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
| 0.2 |
0.3 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 |
5.3 |
GO:0033013 |
tetrapyrrole metabolic process(GO:0033013) |
| 0.2 |
0.6 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.1 |
0.4 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.1 |
0.1 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.1 |
0.9 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.1 |
0.1 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 |
0.6 |
GO:0009062 |
fatty acid catabolic process(GO:0009062) |
| 0.1 |
0.6 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.1 |
0.1 |
GO:0050913 |
sensory perception of bitter taste(GO:0050913) |
| 0.1 |
0.6 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 |
0.7 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.1 |
0.3 |
GO:0003014 |
renal system process(GO:0003014) |
| 0.1 |
0.6 |
GO:0003253 |
cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
| 0.1 |
0.3 |
GO:0009446 |
putrescine metabolic process(GO:0009445) putrescine biosynthetic process(GO:0009446) |
| 0.1 |
0.4 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.1 |
1.0 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 |
3.4 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
0.3 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.1 |
6.2 |
GO:0009142 |
nucleoside triphosphate biosynthetic process(GO:0009142) |
| 0.1 |
0.4 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.1 |
0.8 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.1 |
0.4 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.1 |
0.1 |
GO:0070669 |
response to interleukin-2(GO:0070669) |
| 0.1 |
0.7 |
GO:0010447 |
response to acidic pH(GO:0010447) |
| 0.1 |
0.1 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 |
2.4 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.1 |
0.6 |
GO:0048308 |
organelle inheritance(GO:0048308) Golgi inheritance(GO:0048313) |
| 0.1 |
0.4 |
GO:0000087 |
mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
| 0.1 |
0.1 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.1 |
0.3 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.1 |
0.4 |
GO:0006760 |
folic acid-containing compound metabolic process(GO:0006760) |
| 0.1 |
1.9 |
GO:0042475 |
odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.1 |
0.4 |
GO:0010884 |
positive regulation of lipid storage(GO:0010884) |
| 0.1 |
1.0 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
| 0.1 |
0.8 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.1 |
1.2 |
GO:0042297 |
vocal learning(GO:0042297) imitative learning(GO:0098596) observational learning(GO:0098597) learned vocalization behavior or vocal learning(GO:0098598) |
| 0.1 |
0.8 |
GO:0001990 |
regulation of systemic arterial blood pressure by hormone(GO:0001990) |
| 0.1 |
1.1 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
| 0.1 |
0.3 |
GO:0007565 |
female pregnancy(GO:0007565) |
| 0.1 |
0.1 |
GO:0060161 |
positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.1 |
2.8 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 |
1.1 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.1 |
0.8 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.1 |
0.7 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 |
0.7 |
GO:0019682 |
glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
| 0.1 |
1.3 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
0.7 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.1 |
0.1 |
GO:0045651 |
positive regulation of macrophage differentiation(GO:0045651) |
| 0.1 |
0.1 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.1 |
0.4 |
GO:0045324 |
late endosome to vacuole transport(GO:0045324) |
| 0.1 |
0.4 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.1 |
0.4 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.1 |
0.4 |
GO:0006855 |
drug transmembrane transport(GO:0006855) |
| 0.1 |
0.1 |
GO:0015697 |
quaternary ammonium group transport(GO:0015697) |
| 0.1 |
0.7 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.1 |
1.6 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.1 |
1.0 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.8 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.1 |
0.4 |
GO:0002090 |
regulation of receptor internalization(GO:0002090) |
| 0.1 |
0.4 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
3.0 |
GO:0018196 |
peptidyl-asparagine modification(GO:0018196) |
| 0.1 |
0.1 |
GO:0015802 |
basic amino acid transport(GO:0015802) |
| 0.1 |
0.1 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.1 |
0.5 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.1 |
0.6 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.1 |
0.9 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.3 |
GO:0002548 |
monocyte chemotaxis(GO:0002548) |
| 0.1 |
1.2 |
GO:2000737 |
negative regulation of stem cell differentiation(GO:2000737) |
| 0.1 |
1.2 |
GO:0042401 |
amine biosynthetic process(GO:0009309) cellular biogenic amine biosynthetic process(GO:0042401) |
| 0.1 |
0.5 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.1 |
1.3 |
GO:0097502 |
protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
| 0.1 |
0.4 |
GO:0034440 |
lipid oxidation(GO:0034440) |
| 0.1 |
0.9 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 |
0.4 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
0.8 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.1 |
0.3 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.1 |
0.5 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.1 |
8.4 |
GO:0043062 |
extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
| 0.1 |
0.5 |
GO:0044068 |
modulation by symbiont of host cellular process(GO:0044068) |
| 0.1 |
1.0 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 |
1.8 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.1 |
0.1 |
GO:0048340 |
paraxial mesoderm morphogenesis(GO:0048340) |
| 0.1 |
0.5 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.1 |
0.1 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 |
1.6 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.1 |
0.1 |
GO:0060393 |
regulation of pathway-restricted SMAD protein phosphorylation(GO:0060393) |
| 0.1 |
0.1 |
GO:0035437 |
maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 |
0.5 |
GO:0055078 |
sodium ion homeostasis(GO:0055078) |
| 0.1 |
0.2 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.1 |
0.1 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.1 |
0.2 |
GO:0071158 |
positive regulation of cell cycle arrest(GO:0071158) |
| 0.1 |
0.1 |
GO:0048669 |
collateral sprouting in absence of injury(GO:0048669) |
| 0.1 |
0.2 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.1 |
0.7 |
GO:0010660 |
regulation of muscle cell apoptotic process(GO:0010660) |
| 0.1 |
0.2 |
GO:0045349 |
interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 0.1 |
0.2 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.1 |
0.6 |
GO:0071357 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.1 |
0.2 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.1 |
0.1 |
GO:2000144 |
positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.1 |
0.2 |
GO:0042447 |
hormone catabolic process(GO:0042447) |
| 0.1 |
2.2 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 |
0.8 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.1 |
0.8 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 |
0.1 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.1 |
1.5 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) |
| 0.1 |
0.1 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) |
| 0.1 |
0.2 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.1 |
0.1 |
GO:0001941 |
postsynaptic membrane organization(GO:0001941) neurotransmitter-gated ion channel clustering(GO:0072578) |
| 0.1 |
0.6 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.1 |
0.9 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.1 |
0.3 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 |
0.1 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.1 |
0.3 |
GO:0032330 |
regulation of chondrocyte differentiation(GO:0032330) |
| 0.1 |
2.7 |
GO:0034620 |
cellular response to unfolded protein(GO:0034620) |
| 0.1 |
1.5 |
GO:0006882 |
cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
| 0.1 |
0.3 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.1 |
0.1 |
GO:0046476 |
glycosylceramide biosynthetic process(GO:0046476) |
| 0.1 |
1.1 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 |
0.2 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.1 |
0.2 |
GO:0042523 |
positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
| 0.1 |
0.6 |
GO:0010543 |
regulation of platelet activation(GO:0010543) |
| 0.1 |
0.3 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.1 |
0.1 |
GO:0070542 |
response to fatty acid(GO:0070542) |
| 0.1 |
1.7 |
GO:0009311 |
oligosaccharide metabolic process(GO:0009311) |
| 0.1 |
0.1 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 0.1 |
0.4 |
GO:0016137 |
glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
| 0.1 |
1.9 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 |
0.3 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 |
0.3 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
1.4 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
0.4 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
0.2 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
4.3 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
0.2 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.1 |
1.1 |
GO:0072337 |
modified amino acid transport(GO:0072337) |
| 0.1 |
0.2 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 |
0.2 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.1 |
0.2 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 |
0.2 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.1 |
0.1 |
GO:0060020 |
Bergmann glial cell differentiation(GO:0060020) |
| 0.1 |
0.1 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.1 |
0.1 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.1 |
0.2 |
GO:0006244 |
pyrimidine nucleotide catabolic process(GO:0006244) |
| 0.1 |
0.1 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.1 |
0.1 |
GO:1903431 |
positive regulation of cell maturation(GO:1903431) |
| 0.1 |
1.1 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.1 |
0.7 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
0.5 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.1 |
0.7 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 |
0.2 |
GO:2000193 |
positive regulation of fatty acid transport(GO:2000193) |
| 0.1 |
0.6 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.1 |
0.2 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.1 |
0.1 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 |
0.4 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.1 |
0.1 |
GO:0042448 |
progesterone metabolic process(GO:0042448) |
| 0.1 |
2.1 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.1 |
2.5 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 |
0.1 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.1 |
0.7 |
GO:2000269 |
regulation of fibroblast apoptotic process(GO:2000269) |
| 0.1 |
0.4 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.3 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 |
1.3 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.1 |
1.6 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.1 |
0.3 |
GO:0021756 |
striatum development(GO:0021756) |
| 0.1 |
0.2 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.1 |
0.1 |
GO:0050746 |
regulation of lipoprotein metabolic process(GO:0050746) |
| 0.1 |
0.3 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.1 |
0.7 |
GO:0046685 |
response to arsenic-containing substance(GO:0046685) |
| 0.1 |
0.2 |
GO:0045023 |
G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
| 0.1 |
1.6 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.1 |
0.2 |
GO:0046668 |
regulation of retinal cell programmed cell death(GO:0046668) |
| 0.1 |
0.1 |
GO:0002888 |
positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
| 0.1 |
1.1 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.1 |
0.2 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 |
0.4 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 |
0.2 |
GO:0034381 |
plasma lipoprotein particle clearance(GO:0034381) |
| 0.1 |
0.2 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.1 |
0.1 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.1 |
0.8 |
GO:0002192 |
IRES-dependent translational initiation(GO:0002192) |
| 0.1 |
0.4 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.1 |
0.3 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 |
0.2 |
GO:1902916 |
positive regulation of protein polyubiquitination(GO:1902916) |
| 0.1 |
0.4 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 |
0.5 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.1 |
0.1 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.1 |
2.5 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
0.3 |
GO:0090670 |
RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) |
| 0.1 |
0.2 |
GO:0070243 |
regulation of thymocyte apoptotic process(GO:0070243) |
| 0.1 |
0.2 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 0.1 |
0.2 |
GO:0090045 |
positive regulation of deacetylase activity(GO:0090045) |
| 0.1 |
0.5 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.1 |
0.1 |
GO:0030947 |
regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.1 |
0.3 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 |
0.3 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.1 |
0.3 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 |
3.7 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.1 |
0.1 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.1 |
0.1 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.1 |
0.2 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 |
0.1 |
GO:0046849 |
bone remodeling(GO:0046849) |
| 0.1 |
0.8 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.1 |
0.3 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 |
0.4 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 |
0.4 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.1 |
0.2 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.1 |
0.5 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.1 |
0.3 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.1 |
0.2 |
GO:0033692 |
cellular polysaccharide biosynthetic process(GO:0033692) |
| 0.1 |
1.0 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.1 |
3.9 |
GO:0016125 |
sterol metabolic process(GO:0016125) |
| 0.1 |
0.3 |
GO:0045006 |
DNA deamination(GO:0045006) |
| 0.1 |
0.4 |
GO:0002224 |
toll-like receptor signaling pathway(GO:0002224) |
| 0.1 |
0.1 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.1 |
0.9 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.1 |
0.1 |
GO:0043312 |
neutrophil degranulation(GO:0043312) |
| 0.1 |
0.2 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.1 |
2.8 |
GO:0009247 |
glycolipid biosynthetic process(GO:0009247) |
| 0.1 |
5.5 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.1 |
0.3 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 |
0.9 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.1 |
2.8 |
GO:0046847 |
filopodium assembly(GO:0046847) |
| 0.1 |
0.3 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 |
0.3 |
GO:0030423 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.1 |
0.1 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.1 |
0.1 |
GO:0002063 |
chondrocyte development(GO:0002063) |
| 0.1 |
0.4 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.1 |
0.3 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
0.1 |
GO:0048010 |
vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.1 |
0.1 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.1 |
0.1 |
GO:0021794 |
thalamus development(GO:0021794) |
| 0.1 |
0.9 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 |
0.1 |
GO:0032530 |
regulation of microvillus organization(GO:0032530) |
| 0.1 |
0.3 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.1 |
0.3 |
GO:1990776 |
cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
| 0.1 |
0.1 |
GO:0070827 |
chromatin maintenance(GO:0070827) |
| 0.1 |
1.3 |
GO:0008593 |
regulation of Notch signaling pathway(GO:0008593) |
| 0.1 |
0.3 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.1 |
0.7 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
0.4 |
GO:0043633 |
polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
| 0.1 |
0.9 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
| 0.1 |
0.7 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.1 |
0.2 |
GO:0090303 |
positive regulation of wound healing(GO:0090303) |
| 0.1 |
1.1 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.1 |
0.2 |
GO:0010960 |
magnesium ion homeostasis(GO:0010960) |
| 0.1 |
0.3 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.1 |
0.1 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.1 |
0.1 |
GO:0034138 |
toll-like receptor 3 signaling pathway(GO:0034138) |
| 0.1 |
0.2 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.1 |
GO:0044144 |
regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.1 |
0.2 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.1 |
0.3 |
GO:0072497 |
mesenchymal stem cell differentiation(GO:0072497) |
| 0.1 |
0.1 |
GO:2000650 |
negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
| 0.1 |
0.6 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.1 |
0.5 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.1 |
0.5 |
GO:0019755 |
one-carbon compound transport(GO:0019755) |
| 0.1 |
0.1 |
GO:0046349 |
amino sugar biosynthetic process(GO:0046349) |
| 0.1 |
0.7 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.1 |
0.6 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.1 |
0.5 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 |
1.2 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.1 |
0.8 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 |
0.1 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 |
0.3 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.1 |
GO:0021855 |
hypothalamus cell migration(GO:0021855) |
| 0.1 |
0.1 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 |
0.9 |
GO:0003073 |
regulation of systemic arterial blood pressure(GO:0003073) |
| 0.1 |
0.1 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.1 |
0.4 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 |
0.3 |
GO:0032233 |
positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.1 |
0.4 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
| 0.1 |
0.1 |
GO:0000479 |
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.1 |
0.1 |
GO:1901894 |
regulation of calcium-transporting ATPase activity(GO:1901894) |
| 0.1 |
0.4 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.1 |
1.7 |
GO:0007173 |
epidermal growth factor receptor signaling pathway(GO:0007173) |
| 0.1 |
0.4 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 |
0.2 |
GO:0019659 |
fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.1 |
0.4 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.1 |
1.2 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 |
0.4 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 |
0.1 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.1 |
0.3 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 |
0.8 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.1 |
0.1 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 0.1 |
0.7 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.1 |
0.1 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.1 |
0.2 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.1 |
0.3 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.1 |
0.1 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.1 |
0.3 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 |
0.9 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.1 |
3.0 |
GO:0006633 |
fatty acid biosynthetic process(GO:0006633) |
| 0.1 |
0.3 |
GO:1901028 |
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
| 0.1 |
0.3 |
GO:0010831 |
positive regulation of myotube differentiation(GO:0010831) |
| 0.1 |
0.1 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
| 0.1 |
0.5 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.1 |
0.3 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 |
0.4 |
GO:0009437 |
carnitine metabolic process(GO:0009437) |
| 0.1 |
0.5 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
0.2 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.1 |
1.2 |
GO:0045661 |
regulation of myoblast differentiation(GO:0045661) |
| 0.1 |
0.3 |
GO:0000466 |
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.1 |
0.2 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 |
0.1 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.1 |
0.3 |
GO:0009267 |
cellular response to starvation(GO:0009267) |
| 0.1 |
0.4 |
GO:0007588 |
excretion(GO:0007588) |
| 0.1 |
0.2 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.1 |
1.8 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.1 |
0.3 |
GO:1905097 |
regulation of guanyl-nucleotide exchange factor activity(GO:1905097) negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.1 |
0.1 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.1 |
0.1 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) |
| 0.1 |
0.6 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.1 |
0.7 |
GO:0032611 |
interleukin-1 beta production(GO:0032611) |
| 0.1 |
0.3 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
0.4 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.1 |
0.1 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.1 |
0.1 |
GO:0044070 |
regulation of anion transport(GO:0044070) |
| 0.1 |
0.1 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.1 |
0.1 |
GO:0007187 |
G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
| 0.1 |
0.1 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.1 |
0.1 |
GO:0045851 |
pH reduction(GO:0045851) |
| 0.1 |
0.1 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.1 |
0.4 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 |
0.1 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.1 |
0.1 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.1 |
0.5 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 |
0.2 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 |
0.7 |
GO:0001562 |
response to protozoan(GO:0001562) |
| 0.1 |
0.4 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
0.1 |
GO:0034285 |
response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.1 |
0.3 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 |
2.0 |
GO:0009636 |
response to toxic substance(GO:0009636) |
| 0.1 |
0.2 |
GO:0070265 |
necrotic cell death(GO:0070265) |
| 0.1 |
1.0 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 |
0.9 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.1 |
1.5 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.1 |
1.6 |
GO:1903008 |
organelle disassembly(GO:1903008) |
| 0.1 |
0.2 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.2 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 |
0.7 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.1 |
0.2 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.1 |
0.7 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.2 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 |
0.1 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.1 |
0.2 |
GO:0060760 |
positive regulation of response to cytokine stimulus(GO:0060760) |
| 0.1 |
0.2 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 |
0.1 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 |
0.6 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
| 0.1 |
0.5 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.1 |
0.1 |
GO:1901184 |
regulation of ERBB signaling pathway(GO:1901184) |
| 0.1 |
0.1 |
GO:0052646 |
alditol phosphate metabolic process(GO:0052646) |
| 0.1 |
0.4 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.1 |
0.3 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.1 |
0.1 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 |
0.7 |
GO:0030168 |
platelet activation(GO:0030168) |
| 0.1 |
0.2 |
GO:0060349 |
bone morphogenesis(GO:0060349) |
| 0.1 |
0.1 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.1 |
0.2 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.1 |
0.1 |
GO:1901856 |
negative regulation of cellular respiration(GO:1901856) |
| 0.0 |
1.5 |
GO:0045333 |
cellular respiration(GO:0045333) |
| 0.0 |
0.0 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 |
0.1 |
GO:1903753 |
negative regulation of p38MAPK cascade(GO:1903753) |
| 0.0 |
1.8 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
0.1 |
GO:1903337 |
positive regulation of vacuolar transport(GO:1903337) |
| 0.0 |
0.2 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 |
0.0 |
GO:0042246 |
tissue regeneration(GO:0042246) |
| 0.0 |
0.1 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.0 |
0.1 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.0 |
0.1 |
GO:0070498 |
interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.0 |
0.1 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.0 |
1.3 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 |
0.1 |
GO:0033687 |
osteoblast proliferation(GO:0033687) |
| 0.0 |
0.6 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.0 |
0.2 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.0 |
0.2 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.0 |
0.7 |
GO:0051291 |
protein heterooligomerization(GO:0051291) |
| 0.0 |
2.6 |
GO:0008654 |
phospholipid biosynthetic process(GO:0008654) |
| 0.0 |
0.2 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 |
0.2 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.0 |
0.4 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.0 |
0.0 |
GO:0021554 |
optic nerve development(GO:0021554) |
| 0.0 |
0.2 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.0 |
0.8 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 |
0.0 |
GO:0032288 |
myelin assembly(GO:0032288) |
| 0.0 |
0.1 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.0 |
0.1 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.0 |
0.6 |
GO:0007229 |
integrin-mediated signaling pathway(GO:0007229) |
| 0.0 |
3.4 |
GO:0098780 |
mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
| 0.0 |
0.3 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.0 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.0 |
0.1 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.0 |
0.3 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 |
0.1 |
GO:0034446 |
substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.0 |
0.2 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 |
0.2 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 |
0.4 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
| 0.0 |
0.5 |
GO:0008589 |
regulation of smoothened signaling pathway(GO:0008589) |
| 0.0 |
0.4 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.0 |
0.2 |
GO:0001569 |
patterning of blood vessels(GO:0001569) |
| 0.0 |
0.2 |
GO:0035646 |
endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.0 |
0.1 |
GO:0032958 |
inositol phosphate biosynthetic process(GO:0032958) |
| 0.0 |
0.0 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.0 |
0.1 |
GO:0060135 |
maternal process involved in female pregnancy(GO:0060135) |
| 0.0 |
0.0 |
GO:0021534 |
cell proliferation in hindbrain(GO:0021534) |
| 0.0 |
0.1 |
GO:0006591 |
ornithine metabolic process(GO:0006591) |
| 0.0 |
0.0 |
GO:0045910 |
negative regulation of DNA recombination(GO:0045910) |
| 0.0 |
0.9 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 |
0.0 |
GO:0060087 |
relaxation of vascular smooth muscle(GO:0060087) |
| 0.0 |
0.1 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.0 |
0.1 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.0 |
0.5 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.0 |
0.0 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.0 |
0.1 |
GO:0003382 |
epithelial cell morphogenesis(GO:0003382) |
| 0.0 |
0.1 |
GO:0038089 |
positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.0 |
0.6 |
GO:0008637 |
apoptotic mitochondrial changes(GO:0008637) |
| 0.0 |
0.2 |
GO:0070374 |
positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
| 0.0 |
0.0 |
GO:2000036 |
regulation of stem cell population maintenance(GO:2000036) |
| 0.0 |
0.1 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.0 |
0.2 |
GO:0070897 |
DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.0 |
0.2 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
0.1 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.0 |
0.3 |
GO:0046902 |
regulation of mitochondrial membrane permeability(GO:0046902) |
| 0.0 |
0.2 |
GO:0033598 |
mammary gland epithelial cell proliferation(GO:0033598) |
| 0.0 |
0.1 |
GO:0019585 |
uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
| 0.0 |
0.0 |
GO:0046607 |
positive regulation of centrosome cycle(GO:0046607) |
| 0.0 |
0.1 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 |
0.2 |
GO:0034142 |
toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.0 |
0.1 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.0 |
0.1 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) |
| 0.0 |
0.2 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
0.6 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.1 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.0 |
0.0 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.0 |
0.2 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.0 |
0.1 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.0 |
0.4 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 |
0.1 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.0 |
0.1 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.0 |
0.1 |
GO:0032402 |
melanosome transport(GO:0032402) |
| 0.0 |
0.1 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 |
0.1 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.0 |
0.1 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.0 |
0.0 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.0 |
0.1 |
GO:0046135 |
pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.0 |
0.3 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 |
0.1 |
GO:1901070 |
guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.0 |
0.0 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.0 |
0.0 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.0 |
0.1 |
GO:0002026 |
regulation of the force of heart contraction(GO:0002026) |
| 0.0 |
0.1 |
GO:2000152 |
regulation of ubiquitin-specific protease activity(GO:2000152) |
| 0.0 |
0.2 |
GO:0042471 |
ear morphogenesis(GO:0042471) |
| 0.0 |
0.1 |
GO:2000378 |
negative regulation of reactive oxygen species metabolic process(GO:2000378) |
| 0.0 |
0.1 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.0 |
0.0 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.0 |
0.2 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.0 |
0.0 |
GO:0009133 |
nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.0 |
1.4 |
GO:0043123 |
positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.0 |
0.0 |
GO:0046626 |
regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.0 |
0.1 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.0 |
0.1 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.0 |
0.2 |
GO:0001837 |
epithelial to mesenchymal transition(GO:0001837) |
| 0.0 |
0.1 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
0.1 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.0 |
0.0 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.0 |
0.0 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.0 |
0.2 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.0 |
0.3 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.0 |
0.0 |
GO:0032048 |
cardiolipin metabolic process(GO:0032048) |
| 0.0 |
0.0 |
GO:0035509 |
negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
| 0.0 |
0.6 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 |
0.1 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.0 |
0.2 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.0 |
0.0 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.0 |
0.0 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 |
0.1 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
0.0 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.0 |
0.0 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.0 |
GO:0070085 |
glycosylation(GO:0070085) |
| 0.0 |
0.0 |
GO:0035137 |
hindlimb morphogenesis(GO:0035137) |
| 0.0 |
0.0 |
GO:0009215 |
purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
| 0.0 |
0.1 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.0 |
0.0 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.0 |
0.0 |
GO:0098781 |
ncRNA transcription(GO:0098781) |
| 0.0 |
0.0 |
GO:1902176 |
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
| 0.0 |
0.1 |
GO:0002097 |
tRNA wobble base modification(GO:0002097) |
| 0.0 |
0.0 |
GO:0072683 |
T cell extravasation(GO:0072683) |
| 0.0 |
0.1 |
GO:0006829 |
zinc II ion transport(GO:0006829) |
| 0.0 |
0.1 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.0 |
0.1 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.0 |
0.1 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.0 |
0.0 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.0 |
0.0 |
GO:0051023 |
regulation of immunoglobulin secretion(GO:0051023) |
| 0.0 |
0.3 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.1 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.0 |
0.1 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.0 |
0.0 |
GO:0034340 |
response to type I interferon(GO:0034340) |
| 0.0 |
0.0 |
GO:0016074 |
snoRNA metabolic process(GO:0016074) |
| 0.0 |
0.0 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.0 |
0.0 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.0 |
0.1 |
GO:0001763 |
morphogenesis of a branching structure(GO:0001763) |
| 0.0 |
0.0 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.0 |
0.1 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.0 |
0.1 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
